Sexually Transmitted Infection | Prevention strategies* | Effectiveness |
---|---|---|
Non-viral infections (Chlamydia trachomatis/Neisseria gonorrhoea/Trichomonas vaginalis/Mycoplasma genitalium/Ureaplasma urealyticum/Treponema pallidum) | •Condoms | •90% effective with perfect use [10] |
•Testing for STIs and treating when necessary | •100% effective unless there is poor adherence to treatment, reinfection or drug resistance | |
•Partner notification | •Reducing onward transmission, reinfection and the cost to make an STI diagnosis [11] | |
Human papilloma virus (HPV) | •Condoms | •Up to 50% [12] |
•Circumcision | •50% [13] | |
•HPV vaccination | •90% [14] | |
Hepatitis A virus (HAV) | •Condoms | •Not known |
•Hepatitis A vaccination | •93% [15] | |
Hepatitis B virus (HBV) | •Condoms | •Not known |
•Hepatitis B vaccination | • > 90% [16] | |
Herpes virus (HSV 1 & 2) | •Condoms | •24% [17] |
•Prophylactic treatment | •48% [17] | |
Human Immunodeficiency Virus (HIV) | •Condoms | •10% [18] |
•Circumcision | •57% [13] | |
•Treatment as prevention | •93% [19] | |
•Preexposure prophylaxis (PrEP) | • > 90% [20] |